Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Paperless Partograph for Management of Low Risk Labor

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02714270
Recruitment Status : Completed
First Posted : March 21, 2016
Last Update Posted : August 2, 2018
Sponsor:
Information provided by (Responsible Party):
Ahmed Mohamed Abbas, Assiut University

Brief Summary:

Paperless partograph is a technique used for monitoring the progress of labor before delivery, and arriving at the accurate time to intervene for ensuring a safe delivery.

The study will be carried out to find out the effectiveness of paperless partograph in management of labor and its effect on maternal and neonatal outcomes


Condition or disease Intervention/treatment Phase
Normal Labor Procedure: modified partograph Procedure: paperless partograph Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 370 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Supportive Care
Official Title: A Randomized Clinical Trial of Paperless Versus Modified World Health Organization Partograph in Management of First Stage of Labour
Actual Study Start Date : December 2016
Actual Primary Completion Date : March 2018
Actual Study Completion Date : June 2018

Arm Intervention/treatment
Active Comparator: modified partograph
routine modified partograph
Procedure: modified partograph
Active Comparator: paperless partograph
paperless partograph with no graph paper
Procedure: paperless partograph



Primary Outcome Measures :
  1. Duration of active phase of labor [ Time Frame: 12 hours ]
    calculated in hours between cervical dilatation more than 3 cm till fully dilated



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion criteria:

  1. Age: 18 to 40 years
  2. Gestational age 38-42 weeks
  3. Singleton pregnancy
  4. Vertex presentation
  5. Women who will accept to participate in the study

Exclusion criteria:

  1. Malpresentation
  2. Induced labour
  3. Multiple pregnancy
  4. Medical diseases with pregnancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02714270


Locations
Layout table for location information
Egypt
Ahmed Abbas
Assiut, Cairo, Egypt, 002
Sponsors and Collaborators
Assiut University
Layout table for additonal information
Responsible Party: Ahmed Mohamed Abbas, Dr, Assiut University
ClinicalTrials.gov Identifier: NCT02714270    
Other Study ID Numbers: WHOP-PP
First Posted: March 21, 2016    Key Record Dates
Last Update Posted: August 2, 2018
Last Verified: August 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes